Pramod Prabhakar Jog, Rahul V Shinde, Sourabh Bharat Sonawale*, Krishna Chaitanya Veligandla
Gastroesophageal reflux is a common symptom in the infants. It is the common reason for which parents seek consultation of paediatricians. The present management of GER starts with position and feeding measures, followed by antacids and prokinetics. The clinical practices for management of Gastroesophageal reflux have been evaluated critically with safety, efficacy, and practical connotations. The evidence on Gastroesophageal reflux conventional therapies and Lactobacillus reuteri DSM 17938 was gathered from the PubMed and SCOPUS indexed journals with no language restriction till December 2019. The probiotic Lactobacillus reuteri DSM 17938 has also shown effective results in the treatment of Gastroesophageal reflux. It could be the upcoming therapy for treating Gastroesophageal reflux in infants.
Published Date: 2021-02-04; Received Date: 2020-12-27